Navigation Links
Liquent Insight Publisher 3.6 Delivers Advanced Submission Capabilities
Date:1/28/2008

Latest Version Offers Most Complete Submission Linking Capabilities

PHILADELPHIA and LONDON, Jan. 28 /PRNewswire/ -- Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, today announced the availability of InSight Publisher(R) 3.6. The latest version of InSight Publisher adds intuitive hyperlinking and cross-reference management to its enhanced functionality set. Since its release in 2006, InSight Publisher has been enabling pharmaceutical companies to create, manage and publish regulatory submissions in both paper and electronic format using a single software application.

With the world's regulatory authorities accepting an increased number of submissions in electronic format, the need to deliver easy-to-navigate documents becomes paramount for submission success. With InSight Publisher 3.6, companies can now enable cross-referencing in all critical stages of submission development -- during authoring and submission preparation, and post publishing. By offering support at all three critical stages, InSight Publisher will help companies streamline the cross-referencing tasks and improve efficiencies during the publishing process.

Liquent expects this newest version of InSight Publisher to not only address core cross-referencing requirements, but also the new cross- referencing complexities brought on by eCTD lifecycle management such as managing cross-sequence references, stale references and more. In 2007, Liquent completed a number of worldwide implementations of InSight Publisher with its clients ahead of the project timelines and on or below budget,

"InSight Publisher continues Liquent's leadership in the regulatory publishing and regulatory information management solutions market," stated Rick Riegel, Liquent's vice president and general manager. "InSight Publisher is part of the Liquent InSight Platform and is the industry's only fully scalable, integrated regulatory information management solution, allowing clients to maximize their business benefits of reusing regulatory information while enabling greater compliance."

Regulatory affairs professionals can evaluate how InSight Publisher can fit into their organization by visiting Liquent's booth at the following industry events:
-- USA: Philadelphia - DIA Electronic Document Management Conference,

February 3-5, 2008

-- EUROPE: Amsterdam - IIR Lifecycle Management of the eCTD,

February 25-28, 2008

-- EUROPE: Barcelona - DIA EuroMeeting, March 3-5, 2008

Additional information about InSight Publisher is available at: http://www.liquent.com.

About The Thomson Corporation

The Thomson Corporation (http://www.thomson.com) is a global leader in providing essential electronic workflow solutions to business and professional customers. With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, scientific research and healthcare. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Thomson Scientific is a business of The Thomson Corporation. Its information solutions assist professionals at every stage of research and development -- from discovery to analysis to product development and distribution. Thomson Scientific information solutions can be found at scientific.thomson.com.


'/>"/>
SOURCE Thomson Scientific
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Competitive Intelligence: Processes to Produce Insights that Matter
2. New insight into factors that drive muscle-building stem cells
3. Insights into cell movement likely to aid immune study, cancer research
4. Patient-Centric Healthcare Study Reveals Key Insights for Pharmaceutical Marketers
5. New insights into deadly heart rhythm disorder
6. Neural Insights Could Bring Better Cochlear Implants
7. New technique reveals insights into lung disease
8. MDs reactions to pharma marketing influenced by brand, side effects: Management Insights
9. Elbit Imaging Ltd. Announces US$19,829,643 Investment in its Subsidiary InSightec Ltd., in an Internal Round of Financing
10. InSightec Ltd. Announces US$30 Million Investment Round
11. Cell Insights May Predict Breast Cancers Spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Neurotechnology , a provider of high-precision ... tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the updated  ... recognition to enable users to check in and out from anywhere via the ...
(Date:3/28/2017)... ... ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio and New ... sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National Advisory Board., ... the clinic from a small start-up to number 78 in the country based on ...
(Date:3/28/2017)... ... 28, 2017 , ... The Lice Treatment Center® booth at ... was a busy spot this year. Liz Solovay and Adrian Picheny, the firm’s ... among camp communities during the upcoming 2017 camping season. “Lice infestations at some ...
(Date:3/28/2017)... ... March 28, 2017 , ... Nurse practitioners and physician ... value increases in the healthcare workforce, according to a survey recently released by ... fairs, and candidate leads to healthcare employers of physicians and advanced practice clinicians. ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... patients for custom smile makeovers without requiring a referral. Trimble Dental ... gum disease treatment, cosmetic dentistry and dental implants. Whether patients have discolored, crooked ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... DIEGO and VANCOUVER, British Columbia, March 27, 2017 ... ) (the "Company" or "Sophiris"), a clinical late-stage ... of patients with urological diseases, today reported fourth ... key corporate highlights. Key Corporate ... Clinical Development for Localized Prostate Cancer. During 2016, ...
(Date:3/27/2017)... , March 27, 2017 BioLineRx ... and immunology, announced today that AGI-134, an immunotherapy for the ... of Agalimmune Ltd., will be featured at the upcoming ... Washington, DC to be held on ... ...
(Date:3/27/2017)... -- The staggering cost of cancer treatment means only ... the latest treatment options against cancer. Even among the ... inadequate or no health insurance and are oftentimes saddled ... modern cancer treatment is almost non-existent for cancer patients ... mission statements of pharmaceutical and biotech companies often quote ...
Breaking Medicine Technology: